Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers
NCT05105243
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Safety Issues
Tolerance
Interventions
DRUG:
CVN766
Sponsor
Cerevance